NCT03736473View on ClinicalTrials.gov

A Phase I Study of MEDI9447 (Oleclumab) in Japanese Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

June 19, 2019

Study Completion Date

June 19, 2019

Conditions

Advanced Solid Malignancies

Interventions

DRUG

MEDI9447 (oleclumab)

MEDI9447 administered intravenously

Trial Locations (1)

104-0045

Research Site, Chūōku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY